JAN (NYSE:JAN – Free Report) had its price objective increased by Cantor Fitzgerald from $30.00 to $34.00 in a research report sent to investors on Thursday, Marketbeat.com reports. Cantor Fitzgerald currently has an overweight rating on the stock.
A number of other brokerages also recently issued reports on JAN. Scotiabank lowered their price target on shares of JAN from $30.00 to $29.00 and set a “sector outperform” rating on the stock in a report on Thursday, June 18th. UBS Group set a $29.00 price objective on shares of JAN in a research note on Thursday, June 18th. Royal Bank Of Canada upped their target price on shares of JAN from $27.00 to $30.00 and gave the stock an “outperform” rating in a report on Friday, May 8th. Barclays increased their target price on shares of JAN from $30.00 to $33.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 7th. Finally, KeyCorp raised their price target on shares of JAN from $28.00 to $29.00 and gave the company an “overweight” rating in a report on Wednesday, June 10th. Two investment analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, JAN presently has a consensus rating of “Buy” and a consensus target price of $29.85.
Check Out Our Latest Research Report on JAN
JAN Stock Up 2.7%
JAN Announces Dividend
The firm also recently declared a monthly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Friday, September 11th will be issued a $0.0475 dividend. The ex-dividend date of this dividend is Friday, September 11th. This represents a c) annualized dividend and a dividend yield of 1.9%. JAN’s dividend payout ratio (DPR) is presently -1,140.00%.
JAN News Summary
Here are the key news stories impacting JAN this week:
- Positive Sentiment: Cantor Fitzgerald raised its price target on JAN to $34 from $30 and maintained an “Overweight” rating. The revised target implies approximately 11.7% upside from the referenced $30.44 price, providing a fresh bullish catalyst. JAN price target increase
- Positive Sentiment: Janus Living’s recent earnings discussion emphasized expansion without long-term debt, which may be reinforcing investor confidence in the company’s ability to grow while limiting balance-sheet risk. Janus Living boosts outlook on debt-free growth
- Positive Sentiment: The company’s latest reported quarter also provided support: JAN earned $0.23 per share, in line with estimates, while revenue of $200.4 million exceeded consensus of $158.0 million.
- Neutral Sentiment: Despite the improved target, JAN remains a growth-oriented stock with a negative reported P/E ratio, so investors will likely continue focusing on revenue growth, profitability, cash generation and execution of its expansion plans.
About JAN
Upon completion of this offering, we will be the only U.S. publicly traded REIT focused exclusively on the senior housing sector and the only U.S. publicly traded REIT whose entire portfolio is owned and operated under RIDEA structures. We have an initial portfolio consisting of 34 senior housing communities, comprised of 10,422 units as of December 31, 2025. Our communities are located primarily in major retirement markets across 10 states, with units in Florida and Texas representing 69% of the total units as of December 31, 2025.
Further Reading
- Five stocks we like better than JAN
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for JAN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JAN and related companies with MarketBeat.com's FREE daily email newsletter.
